Delivery Order SPE2DX22D0029-SPE2D826F12KH
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $74,044.06 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside, competitively awarded contract represents a single delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The work will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,785.54 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child order under a larger Indefinite Delivery Contract vehicle with a ceiling value of $999,999,999.00 that runs through December 2026. The delivery order is scheduled for completion by January 7, 2026, with performance occurring at the company's corporate office...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,109.36 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was not set-aside and was competitively awarded. The contract represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $57,639.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, competitively awarded delivery order represents no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under Amerisourcebergen Drug Corp's existing...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,851.80 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026. The delivery order...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $116,789.40 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set aside for any specific business type, has an ultimate completion date of January 7, 2026, and represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is Conshohocken,...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F12KHDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at $999,999,999.00 and runs through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This contract exemplifies Amerisourcebergen's critical role as a pharmaceutical prime vendor to federal medical procurement. The company supplies a broad spectrum of pharmaceutical products and medical commodities—including brand-name and generic medications, vaccines, specialty drugs for conditions such as diabetes and neurological disorders, and medical devices—to support military treatment facilities and other government healthcare systems. The delivery order structure and firm fixed pricing are consistent with the company's standard federal contracting approach, which has demonstrated its capability to meet federal procurement requirements through open competition across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 1/5/26 |